What Is Drug Resistance? Understanding the Basics
8th February 2025, Saturday
Drug resistance in cancer patients is one of the biggest challenges in treatment. Cancer cells learn to evade or withstand the effects of treatment, which manifests as treatment failure, making it even more complicated to manage the disease.
Inability of Treatment to Manage Cancer: What Does This Mean?
Drug resistance occurs when the cancer cells stop being responsive to treatment like they initially did. Some patients may have part responses while others may relapse regardless of adhering to best treatment practices. In the extreme instances, resistance develops within a few weeks while in others; it can take months or even years, as per Dr. Kulkarni’s observation in an interview with HT Lifestyle.
He has added that even though the treatment has become ineffective against the cancer, it does not mean that the body is becoming resistant. Instead, the body has adapted to work not withstanding the cancer.
Chemotherapy treatment is similar to a shotgun. It kills rapidly dividing cells and these cells comprise, as in the case of cancer, normal cells in the bone marrow, the digestive tract, and also the hair follicles. Resistance also happens when cancer cells mutate or use other methods to survive the treatment, so that it becomes less effective or entirely futile, over time.
Also Read: Ananya Panday says goodbye to sequins, opts for mirrorwork for a ‘Demure’ baraati look
What Causes Drug Resistance in Cancer Patients?
According to Dr. Anjali Kulkarni, drug resistance does not occur for a single reason. The multiplicity of conditions that determine the occurrence of drug resistance includes cancer cells, an altered microenvironment, the immune system as well as metabolic changes.
“Cancer cells within a tumor may possess different molecular markers, some of which cause drug resistance. Tumor burden and specific genetic changes also influence a patient’s response to the treatment.”
Dr. Sandeep Nayak extended his argument with a few mechanisms concerning resistance to cancer treatment:
Genetic Mutations of Cancer Cells: In some cases, cancer cells have mutations that make them to be less sensitive to treatment. For example, EGFR mutations lead to resistance to targeted therapy using tyrosine kinase inhibitors.
Drug Efflux Mechanisms: For instance, cancer cells produce proteins like P-glycoprotein, which pumps out the drug to make it less effective.
Tumor Microenvironment: The microenvironment, which for example includes the immune cells, blood vessels, and the extracellular matrix, can prevent treatment against ca sarcoma wound infections. A case may be providing hypoxia within the tumor to decrease the effectiveness of radiation therapy, for example, when oxygen levels are very low.
Cancer Stem Cells: Some tumors contain cancer stem cells which are treatment insensitive and are able to regenerate the tumor after therapy.
Epigenetic Changes: Changes in gene expression can take place even without changes in the sequence of the DNA by the cancer cell itself in regards to a drug. Such as silencing of genes making the person vulnerable.
Immune Evasion: In the case of immunotherapy, some cancer cells evade the immune system by down-regulating molecules such as PD-L1 or mutating key antigens.
Fighting Resistance to Drugs in Cancer Therapy
Understanding mechanisms of drug resistance is important for the design of better personalized therapies for cancer patients. Scientists are investigating new therapies, combinations, and precision medicine for the development of new approaches to counteract treatment failures and improve patient outcomes.
Conclusion
Drug resistance represents one of the largest obstacles to successful cancer treatment:
often leading to disease progression and subsequent treatment failures. Cancer cells evolve as a result of such genetic mutations, altered drug metabolism, immune evasion, and environmental adaptations, which have rendered the majority of traditional therapies ineffective over time.
Yet, advances are promising in cancer research. Combination therapy, targeted and immunotherapeutic approaches and precision medicine are showing doctors being able to “overcome” resistance and improve outcomes for patients. Knowledge of mechanisms behind the resistance to drugs should give rise to novel ideas that need to be explored to enable more effective and personal treatment application.
Drug resistance is actually among the biggest obstacles in cancer treatment, as it often leads to disease progression alongside its treatment failures. Such genetic mutations, altered drug metabolism, immune evasion, and environmental adaptations evolve cancer cells over time, rendering almost all of the conventional therapies ineffective.
Nevertheless, research fray in cancer seems to give hope, as combined strategies such as combination therapies, targeting treatment, immunotherapy, and precision medicine tend to empower doctors to “overcome” resistance and improve patient outcomes. Such knowledge concerning mechanisms behind the resistance to drugs should give rise to novel ideas that have to be explored to make more effective and personalized applications of treatment.
Also Read: Manish Malhotra closes Dubai Fashion Week 2025 with a star-studded show
